Cornercap Investment Counsel Inc I Teos Therapeutics, Inc. Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$10.33 - $18.09 $1,249 - $2,188
-121 Reduced 0.91%
13,119 $194,000
Q4 2023

Jan 30, 2024
BUY
$8.57 - $11.06 $445 - $575
52 Added 0.39%
13,240 $144,000
Q3 2023

Nov 13, 2023
BUY
$10.95 - $14.6 $6,909 - $9,212
631 Added 5.03%
13,188 $144,000
Q1 2023

May 11, 2023
BUY
$13.02 - $22.62 $163,492 - $284,039
12,557 New
12,557 $170,000

Others Institutions Holding ITOS

# of Institutions
165
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $293M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email